Načítá se...
Intravenous immunoglobulin: prospects in patients with autoimmune rheumatic diseases
The published data on efficiency of intravenous immunoglobulin (IVIG) in patients with autoimmune rheumatic diseases (RD) are analyzed. IVIG is the drug of choice in patients with Kawasaki disease, idiopathic thrombocytopenic purpura, dermatomyositis, etc. It is reasonable to use IVIG in RD patients...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
IMA-PRESS LLC
2014-03-01
|
| Edice: | Современная ревматология |
| Témata: | |
| On-line přístup: | https://mrj.ima-press.net/mrj/article/view/510 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|